Genip Plc Regulatory News (GNIP)

26 March 2025 

GenIP Plc

("GenIP" or the "Company")

Contract Win

GenIP Plc, a technology business providing Generative Artificial Intelligence (GenAI) services to help research organisations and corporations commercialise their innovations, is pleased to announce it has secured a contract worth approximately USD$65,000 with a Singapore-based research institute (the "Client").

This contract, covering the delivery of 100 GenAI-enhanced analytical assessments, is part of a wider bid process with leading Asian institutions referred to in GenIP's announcement 13 March 2025.

The award results from GenIP's ongoing sponsorship of key technology transfer initiatives and marketing activities in leading Southeast Asian technology hubs.

Analytical assessment revenue will be recognised upon report production by GenIP and delivery to the Client.

Melissa Cruz, CEO of GenIP, commented:

"We are delighted to partner with a leading research and innovation institution in Singapore to accelerate the commercialisation of new technological discoveries. This collaboration demonstrates the broad application of our technology evaluation services by supporting cutting-edge clinical and healthcare research and innovation. Furthermore, this contract underscores the significant size of the addressable market for our technology commercialisation services."

For further information regarding GenIP, please visit www.genip.ai, or contact:

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.